Pages that link to "Q37761262"

The following pages link to Drug delivery systems. 6. Transdermal drug delivery (Q37761262):

Displaying 37 items.

• Context-dependent effects of steroid chemosignals on human physiology and mood (Q28216610) (← links)
• Transdermal rotigotine: a clinically innovative dopamine-receptor agonist for the management of Parkinson's disease (Q28266116) (← links)
• Permeabilization and recovery of the stratum corneum in vivo: the synergy of photomechanical waves and sodium lauryl sulfate (Q31009463) (← links)
• Partial ablation of porcine stratum corneum by argon-fluoride excimer laser to enhance transdermal drug permeability (Q33210168) (← links)
• Tuftsin-bearing liposomes in treatment of macrophage-based infections. (Q33852973) (← links)
• Pharmacotherapy of opioids: present and future developments (Q34401942) (← links)
• Transdermal fentanyl (Q35653349) (← links)
• Skin metabolism in transdermal therapeutic systems (Q36134752) (← links)
• Use of transdermal drug formulations in the elderly (Q37117105) (← links)
• Role of topical peptides in preventing or treating aged skin (Q37537638) (← links)
• Prodrug strategies for enhancing the percutaneous absorption of drugs. (Q38290414) (← links)
• Percutaneous absorption of chemicals: developing an understanding for the treatment of disease in frogs (Q38604629) (← links)
• Topical analgesic added to paraffin enhances paraffin bath treatment of individuals with hand osteoarthritis (Q39283330) (← links)
• Transdermal therapy for overactive bladder: present and future. (Q40286719) (← links)
• Physical enhancement of dermatologic drug delivery: iontophoresis and phonophoresis (Q40970596) (← links)
• A novel metered dose transdermal spray formulation for oxybutynin (Q41985423) (← links)
• Formulation and biopharmaceutical evaluation of a transdermal patch containing letrozole (Q43169259) (← links)
• Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: treatment with meclizine (Q43248405) (← links)
• Azone enhances clinical effectiveness of an optimized formulation of triamcinolone acetonide in atopic dermatitis (Q43651020) (← links)
• Epidermal enzymes as penetration enhancers in transdermal drug delivery? (Q43870630) (← links)
• Controlled transport of timolol maleate through artificial membranes under passive and iontophoretic conditions (Q44014422) (← links)
• FTIR imaging for the characterization of controlled-release drug delivery applications (Q44131183) (← links)
• In vitro evaluation of the release of albuterol sulfate from polymer gels: effect of fatty acids on drug transport across biological membranes (Q44245332) (← links)
• Skin contamination by oestradiol gel--a remarkable source of error in plasma oestradiol measurements during percutaneous hormone replacement therapy (Q45000192) (← links)
• Transdermal delivery of salbutamol sulphate: formulation and evaluation. (Q45973098) (← links)
• Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation (Q46454374) (← links)
• Pharmacokinetics, tolerability, and performance of a novel matrix transdermal delivery system of fentanyl relative to the commercially available reservoir formulation in healthy subjects (Q48697154) (← links)
• Optimization and Formulation Design of Gels of Diclofenac and Curcumin for Transdermal Drug Delivery by Box-Behnken Statistical Design (Q51675342) (← links)
• Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals (Q64077456) (← links)
• Penetration kinetics of 2',3'-dideoxyinosine in dermis is described by the distributed model (Q72175719) (← links)
• Percutaneous absorption of 2',3'-dideoxyinosine in rats (Q72746258) (← links)
• A comparative study of the transdermal penetration of a series of nonsteroidal antiinflammatory drugs (Q73236935) (← links)
• Transdermal iontophoresis of tacrine in vivo (Q74312513) (← links)
• Synthesis and bioactivity of fatty acid-conjugated GnRH derivatives (Q77827617) (← links)
• Transdermal oxybutynin for overactive bladder (Q79163728) (← links)
• Collagen Hydrolysates for Skin Protection: Oral Administration and Topical Formulation (Q89879534) (← links)
• Influence of drug lipophilicity on terpenes as transdermal penetration enhancers (Q93924864) (← links)